Back to Journals » Clinical Ophthalmology » Volume 13

Clinical Trial Report

A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease

         
Total article views   Abstract views HTML views PDF downloads Totals
6,178 Dovepress* 4,475 822+ 1,751 5,297
PubMed Central* 0 881 190 881
Totals 4,475 1,703 1,941 6,178
*Since 12 February 2019
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar